To save lives and end breast cancer forever by empowering people, ensuring quality care for all and energizing science to find the cures
Since 1982, Komen has played a critical role in every major advance in the fight against breast cancer transforming how the world talks about and treats this disease and helping to turn millions of breast cancer patients into breast cancer survivors
More early detection and effective treatment - Currently, about 70 percent of women 40 and older receive regular mammograms, the single most effective screening tool to find breast cancer early. Since 1990, early detection and effective treatment have resulted in a 33 percent decline in breast cancer mortality in the U.S.
More hope - In 1980, the 5-year relative survival rate for women diagnosed with early stage breast cancer was about 74 percent. Today, that number is 98 percent.
More research - The federal government now devotes more than $850 million each year to breast cancer research, treatment and prevention (compared to $30 million in 1982).
More survivors - Currently, there are about 3 million breast cancers survivors, the largest group of cancer survivors in the U.S.